Acumen Pharmaceuticals, Inc. (ABOS)
CIK 1576885 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Acumen Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 12, 2026 | 10-Q | 0001628280-26-056199 |
| Aug 12, 2026 | S-8 | 0001628280-26-056240 |
| Aug 12, 2026 | 8-K | 0001628280-26-055940 |
| Jun 17, 2026 | 4 | 0001628280-26-043987 |
| Jun 17, 2026 | 144 | 0001950047-26-006245 |
| Jun 16, 2026 | 144 | 0001950047-26-006235 |
| Jun 16, 2026 | 8-K | 0001628280-26-043416 |
| Jun 15, 2026 | 144 | 0001950047-26-006161 |
| Jun 10, 2026 | 4 | 0001628280-26-042280 |
| Jun 9, 2026 | 144 | 0001950047-26-005810 |
| Jun 5, 2026 | 4 | 0001628280-26-041273 |
| Jun 5, 2026 | 4 | 0001628280-26-041281 |
| Jun 5, 2026 | 4 | 0001231919-26-000604 |
| Jun 5, 2026 | 4 | 0001628280-26-041268 |
| Jun 5, 2026 | 4 | 0001628280-26-041263 |
| Jun 5, 2026 | 4 | 0001628280-26-041276 |
| Jun 5, 2026 | 4 | 0001628280-26-041272 |
| Jun 5, 2026 | 4 | 0001628280-26-041270 |
| Jun 3, 2026 | 8-K | 0001628280-26-040447 |
| May 12, 2026 | 10-Q | 0001628280-26-034204 |
| May 12, 2026 | 8-K | 0001628280-26-033868 |
| Apr 23, 2026 | DEF 14A | 0001628280-26-026870 |
| Apr 23, 2026 | ARS | 0001628280-26-026874 |
| Apr 23, 2026 | DEFA14A | 0001628280-26-026871 |
| Apr 7, 2026 | SCHEDULE 13G | 0001140361-26-013660 |